EpiPen Shortage 2018: 13 Things for Parents to Know

An EpiPen shortage has parents worried as the school season starts back up across the U.S.

EpiPen Shortage 2018: 13 Things for Parents to Know
Source: Shutterstock

Here are a few things to know about the EpiPen shortage.

  • This isn’t simply a case of parents worry too much about their children.
  • The U.S. Food and Drug Administration has confirmed that there is in fact a shortage of EpiPens.
  • The shortage has actually been going on for months, but is only kick up more dust lately as school starts.
  • The reason behind the delay has to do with manufacturing issues.
  • There are also problems with supply distribution that are causing the EpiPen shortage.
  • Mylan NV (NASDAQ:MYL), the creator of EpiPen, says it doesn’t know when the shortage will end.
  • Adding to the shortage are the quick expiration dates for the medicine, which only lasts for 18 months.
  • Parents are also required to send doses of the drug that haven’t expired to schools for their child’s use.
  • Any parents that have concerns about the EpiPen shortage do have other options.
  • There are other companies that make epinephrine devices that their children could use in an emergency.
  • Adrenaclick is Amneal Pharmaceuticals’ (NYSE:AMRX) version of EpiPen.
  • Kaleo is another company that offers epinephrine devices that parents can use.
  • There’s more hope on the horizon as the FDA has approved a generic version of EpiPen from Teva Pharmaceutical (NYSE:TEVA).

You can follow these links to learn more about the EpiPen shortage and the other epinephrine alternatives that are available.

As of this writing, William White did not hold a position in any of the aforementioned securities.

Article printed from InvestorPlace Media, https://investorplace.com/2018/08/epipen-shortage-things-to-know/.

©2020 InvestorPlace Media, LLC